Vicarious Surgical Public Company (NYSE:RBOT)

Primary contact

🚀 Merged with D8 Holdings Corp. on April 15, 2021. in a SPAC deal worth $1.1B, raising $425M in the process.
Vicarious Surgical combines virtual reality with proprietary human-like surgical robotics to improve visibility and accuracy, and enable surgeons to perform minimally invasive surgery through a single micro-incision. The company's team of engineers hailing from MIT, Stanford, and Harvard University work together to break ground on new and relevant surgical robotics technology. Vicarious Surgical's technology was granted Breakthrough Device Designation by the U.S. FDA, making it the first, and only, surgical robot to receive this designation from the FDA.
Primary contact

Funding 💰

Total $43.2M
Select investors Khosla Ventures, AME Cloud Ventures, Innovation Endeavors, Gates Ventures, Marc Benioff, UpHonest Capital, Rothenberg Ventures
Last update: September 4, 2021